The pseudouridine synthase PUSL1 modifies U39 of mitochondrial tRNAs and is linked to human neurological phenotypes
Nucleic Acids Research · 2026
DOI: 10.1093/nar/gkag805 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2026. Verfasst von Pedro Rebelo-Guiomar und 8 weiteren Autor:innen. Beteiligte Einrichtung: MRC Mitochondrial Biology Unit, University of Cambridge, Cambridge CB2 0XY, United Kingdom. Hauptthemen laut MEDLINE: Intramolecular Transferases, RNA, Transfer, RNA. Die Arbeit nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Fundação para a Ciência e a Tecnologia, Israel Science Foundation.
Abstract (Originalsprache)
Variants in the mitochondrial and nuclear genomes are linked to a wide range of human disorders marked by impaired mitochondrial function. Among these disorders, there is a growing number of patients with variants affecting mitochondrial RNA biology. Mitochondrial transcripts are pseudouridylated, and some enzymes responsible for this modification—pseudouridine synthases (PUS)—have been identified. Although known as the ‘fifth nucleotide’ owing to its high abundance in transcripts, the exact cellular role of pseudouridine is still unclear. Here, we expand the group of mitochondrial PUS enzymes by demonstrating that the protein encoded by PUSL1 is an active pseudouridine synthase with mitochondrial localization. Nucleotide-resolution pseudouridine mapping (mito-Ψ-Seq) followed by primer extension analysis showed that PUSL1 selectively modifies universal position 39 of all mitochondrial transfer RNAs (tRNAs) with a uridine residue in this position. Two newly described clinical PUSL1 variants, c.704G > A (p.Arg235Gln) and c.634del, p.Glu212Argfs*26, were functionally studied, presenting defects in pseudouridylation of mt-tRNA position 39 in patient-derived material, corroborating the association of this enzyme with human pathology. Our data show that PUSL1 regulates mitochondrial RNA post-transcriptional processing and its dysfunction and could be associated with neurological phenotypes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- MRC Mitochondrial Biology Unit, University of Cambridge, Cambridge CB2 0XY, United Kingdom.
- The Shmunis School of Biomedicine and Cancer Research, The George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, 69978, Israel.
- National Center of Genetics (NCG), Laboratoire National de Santé (LNS), Dudelange 3555, Luxembourg.
- Department of Medical Genetics, Reference Centre for Mitochondrial Diseases, Nice Teaching Hospital, 06200 Nice, France.
- IRCAN, UMR 7284/INSERM U1081/UCA, School of Medicine, Nice Côte d'Azur University, 06107 Nice, France.
- Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, 7610001, Israel.
ORCID-Profile: Pedro Rebelo-Guiomar, Schraga Schwartz, Aldema Sas-Chen, Michal Minczuk
Förderung
- Medical Research Council
- Fundação para a Ciência e a Tecnologia
- Israel Science Foundation
- European Research Council
- Fundação para a Ciência e a Tecnologia
Zitieren
APA
Rebelo-Guiomar, P., Kra-Oz, N., Powell, C., Jouret, G., Plutino, M., Paquis-Flucklinger, V., Schwartz, S., Sas-Chen, A., & Minczuk, M. (2026). The pseudouridine synthase PUSL1 modifies U39 of mitochondrial tRNAs and is linked to human neurological phenotypes. Nucleic Acids Research. https://doi.org/10.1093/nar/gkag805
Vancouver
Rebelo-Guiomar P, Kra-Oz N, Powell C, Jouret G, Plutino M, Paquis-Flucklinger V, et al. The pseudouridine synthase PUSL1 modifies U39 of mitochondrial tRNAs and is linked to human neurological phenotypes. Nucleic Acids Research. 2026. doi:10.1093/nar/gkag805
BibTeX
@article{RebeloGuiomar2026,
author = {Rebelo-Guiomar, Pedro and Kra-Oz, Nadav and Powell, Christopher and Jouret, Guillaume and Plutino, Morgane and Paquis-Flucklinger, Veronique and Schwartz, Schraga and Sas-Chen, Aldema and Minczuk, Michal},
title = {The pseudouridine synthase PUSL1 modifies U39 of mitochondrial tRNAs and is linked to human neurological phenotypes},
journal = {Nucleic Acids Research},
year = {2026},
doi = {10.1093/nar/gkag805}
}
EUVIMED